Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of regimens with and without meropenem in Acinetobacter infection
IRCT20240117060720N1Phase 3Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of meropenem in sepsis and pneumonia, sponsored by Gonabad University of Medical Sciences. Started Jun 2024; status: completed.
02
Drugs
meropenem
03
Conditions
sepsispneumonia
Beyond the preview
Go deeper on IRCT20240117060720N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240117060720N1.